Pharmaceutical Executive
Drug giant is streamlining R&D to focus on five disease areas--three of them new.
Pharmaceutical Executive-02-21-2007
Pharmaceutical Executive
First-ever Advance Market Commitment offers guaranteed price for vaccines in poor countries.
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
